1-155610565-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3PP5
The NM_018116.4(MSTO1):c.220+5G>C variant causes a splice region, intron change. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018116.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSTO1 | ENST00000245564.8 | c.220+5G>C | splice_region_variant, intron_variant | Intron 2 of 13 | 1 | NM_018116.4 | ENSP00000245564.3 | |||
MSTO1 | ENST00000368341.8 | c.220+5G>C | splice_region_variant, intron_variant | Intron 2 of 12 | 2 | ENSP00000357325.4 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 9AN: 143732Hom.: 0 Cov.: 19 FAILED QC
GnomAD3 exomes AF: 0.0000325 AC: 2AN: 61574Hom.: 0 AF XY: 0.0000323 AC XY: 1AN XY: 30986
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000761 AC: 57AN: 749220Hom.: 0 Cov.: 10 AF XY: 0.0000680 AC XY: 26AN XY: 382472
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000626 AC: 9AN: 143732Hom.: 0 Cov.: 19 AF XY: 0.0000720 AC XY: 5AN XY: 69484
ClinVar
Submissions by phenotype
See cases Pathogenic:1
The c.220+5 variant in MSTO1 has been identified in compound heterozygosity with a likely pathogenic missense change (c.65A>G, p.Ala22Glu) in three siblings affected with typical MSTO1-assciated myoptahy, cerbellar atrophy and corticospinal track involvement and previously unreported bilateral optic neuropathy responsible for profound central visual loss. Biallelism has been demonstrated experimentaly. The change is known as rs1187504822 and is extremely rare with a minor allele frequency of 0.003%. The variant is predicted to abolish the donor splice-site of intron 2, induce exon skipping and introduce a premature termination codon in the mRNA. The mRNA encoded by the allele carrying the c.200+5G>C variant is undetectable in cells from affected individuals, suggesting nonsense-mediated mRNA decay. In summary, the c.220+5G>C variant meets our criteria to be classified as pathogenic based upon phenotype, family history, segregation studies, rarity in large population studies, computational evidence supporting deleterious effect and mRNA analysis. -
not provided Pathogenic:1
Intronic variant directly or indirectly altering the +5 splice site in a gene for which loss of function is a known mechanism of disease, and splice predictors support a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 37431816) -
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at